HCPLive

Hyperbaric Oxygen Shows No Benefit for Diabetic Foot Ulcers

THURSDAY, Feb. 28 (HealthDay News) -- For patients with diabetic foot ulcers, use of hyperbaric oxygen (HBO) is not associated with improved healing or with a decrease in the likelihood of amputation, according to a study published online Feb. 19 in Diabetes Care.

David J. Margolis, MD, PhD, from the University of Pennsylvania, in Philadelphia, and colleagues compared the effectiveness of HBO with other conventional therapies in a longitudinal observational cohort study including 6,259 individuals with diabetes, adequate lower limb arterial perfusion, and foot ulcers extending through the dermis.

In propensity score-adjusted models, the researchers found that individuals receiving HBO were significantly less likely to have healing of their foot ulcer (hazard ratio, 0.68) and significantly more likely to have an amputation (hazard ratio, 2.37). HBO was not found to improve the likelihood of wound healing or to reduce the likelihood of amputation in additional analyses including use of an instrumental variable to ascertain the robustness of the results to unmeasured confounding.

"In conclusion, HBO did not appear to be useful for the prevention of amputation and did not improve the likelihood that a wound would heal in a cohort of patients defined by Centers for Medicare and Medicaid Services eligibility criteria," write the authors.

Two authors disclosed financial ties to the National Healing Corp. One of the authors is a consultant to Healogics, which fully owns the National Healing Corporation.

Abstract
Full Text (subscription or payment may be required)

Copyright © 2013 HealthDay. All rights reserved.

Most Popular

Recommended Reading

The saying “it’s all in your head” may not be that far off when it comes to pain, according to a new study measuring brain activity.
Researchers at ATS 2015 reported chronic obstructive pulmonary disease was a risk factor for cardiovascular disease, but was not independently linked to risk of stroke or systemic embolism.
Researchers at Oregon State University have identified zebrafish as an optimal testing model for toxoplasmosis, as they believe the fish could provide insight into breakthrough treatments.
Besides being the most common cause of chronic liver disease in industrialized nations, non-alcoholic fatty liver disease has serious hepatic consequences. It is expected to be the most frequent indication for liver transplantation by 2030.
$vAR$